Biotech

All Articles

Kairos goes public with $6M IPO to fund trials of cancer cells medication

.Along with a trio of biotechs hitting the Nasdaq on Friday, it was actually effortless to skip a sm...

Vaccine and Keytruda combination effective in squamous cell carcinoma

.Immune checkpoint inhibitors are actually the superheroes of cancer therapy. Medicines like Bristol...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as...

Regeneron's Opdualag competitor presents 57% action rate

.Regeneron is actually back along with long-lasting consequence for its LAG-3 prevention and also PD...

AstraZeneca posts data on internal opponents to AbbVie, Pfizer ADCs

.AstraZeneca has actually shared a very early examine the performance of its internal antibody-drug ...

iTeos- GSK's TIGIT superstar shows relevant renovation

.After declaring a stage 3 launch based on beneficial midstage outcomes, iTeos and GSK are ultimatel...

More collective FDA can easily accelerate rare health condition R&ampD: document

.The FDA should be more open and joint to unleash a rise in approvals of rare health condition drugs...

Zenas, MBX, Bicara scalp to Nasdaq in hot time for biotech IPOs

.It is actually an abnormally active Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bic...

Atea's COVID antiviral falls short to halt hospitalizations in stage 3

.Atea Pharmaceuticals' antiviral has actually failed yet another COVID-19 test, however the biotech ...

Neurocrine's proposal to spare schizophrenia possibility stops working

.Neurocrine Biosciences' schizophrenia course pivot has fallen short. The biotech was not able to re...